 10. Patients receiving anticoagulation therapy with Coumadin are not eligible for study. Patients on non-coumadin anticoagulants Lovenox, Xarelto, etc. are eligible for study. Patients on Coumadin who can be transitioned to lovenox prior to starting study treatments will be eligible. 